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UNIVENTRICULAR REPAIR 
Early and midterm results 
A total of 202 patients (62 with tricuspid atresia and 140 without tricuspid 
atresia) underwent univentricular epair at our unit from January 1990 to 
September 1994. Of these patients, 182 had nonfenestrated and 20 had 
fenestrated interatrial baffles. Early mortality was 15.9% (29/182) in the 
group with nonfenestrated baffles and 5% (1/20) in the group with 
fenestrated baffles. The follow-up period ranged from 2 to 58 months. Seven 
late deaths occurred, and five patients were lost to follow-up. Of 160 
patients who have been evaluated in the outpatient department in the past 
3 months, 142 (88.75%) required no cardiac medicines and were in 
functional class I. Risk factors analyzed for early mortality and significant 
effusion were age, preoperative diagnosis, type of Fontan modification, 
cardiopulmonary bypass time, aortic crossclamp time, pulmonary artery 
size, associated pulmonary arterioplasty, takedown of systemic-pulmonary 
artery shunt, and pulmonary artery debanding, along with the Fontan 
operation. Bypass time exceeding 120 minutes was associated with a higher 
early mortality (12/47 vs 18/155; p = 0.0187). Bypass time xceeding 120 
minutes (p = 0.0456) and aortic crossclamp time exceeding 60 minutes (p = 
0.0278) were associated with significant postoperative effusion. Other 
factors were not associated with any significantly increased risk for early 
mortality or postoperative ffusions. Fenestration of the interatrial baffle 
appeared to decrease early mortality, although the numbers are too small 
to be statistically significant. The prevalence of effusions did not differ 
significantly between the group with fenestrated baffles and the group without 
fenestrated baffles. (J THORAC CARDIOVASC SURG 1995;110:1692-701) 
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S ince the first univentricular epair described by Fontan and Baudet 1 in 1971, the basic concept of 
systemic ve in-pu lmonary artery connection has 
been modif ied many times. 2-8 In the early era oper- 
ative mortal ity was high, ranging from 17% to 
21%.9, 10 Recent results are more encouraging be- 
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cause of the introduction of total cavopulmonary con- 
nection, 11 an interim bidirectional connection between 
the superior vena cava and pulmonary artery as staged 
palliation,12,13 and, finally, baffle fenestration. 14-16 
This study was designed to analyze our experience 
with univentricular epair and especially to review 
the effects of baffle fenestration on outcome. 
Patients and methods 
A total of 202 patients who underwent univentricular 
repair from January 1990 to September 1994 form the 
subject of this study. The group included 149 male and 53 
female patients. Mean age was 7.32 years (standard 
deviation 6.13 years, range 0.6 to 52 years). Age distribu- 
tion of these patients is shown in Fig. 1. Sixty-sLx patients 
had palliation before the Fontan operation: Blalock- 
Taussig shunt, n = 58; Waterston shunt, n = 1; pulmonary 
artery banding, n = 3; and bidirectional Glenn shunt, 
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Fig. 1. Age distribution and Fontan failure. 
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n = 4. Underlying diagnoses were tricuspid atresia in 62 
patients, complex congenital heart disease with functional 
single ventricle in 139 patients, and right ventricular 
tumor in 1 patient (Table I). 
Selection criteria used for the Fontan operation in- 
cluded functional single ventricle in combination with the 
following: 
1. Satisfactory pulmonary artery size 
2. Reparable localized pulmonary artery stenosis with 
good distal branch pulmonary arteries 
3. Pulmonary artery pressure less than 18 mm Hg or less 
than 20 mm Hg with net left-to-right shunt 
4. Satisfactory ventricular function (end-diastolic pressure 
<12 mm Hg and/or angiographically good ventricular 
function) with no significant ventricular hypertrophy 
5. No left ventricular outflow tract obstruction 
6. No more than mild atrioventricular valve regurgitation 
Preoperative McGoon ratio ranged from 1.2 to 4.5 (mean 
2.46, standard eviation 0.56), mean pulmonary artery pres- 
sure ranged from 5 to 20 mm Hg (mean 11.05 mm Hg, 
standard eviation 5.29 mm Hg), and left ventricular end- 
diastolic pressure ranged from 3 to 15 mm Hg (mean 10.72 
mm Hg, standard eviation 3.94 mm Hg). Fifteen patients 
had stenosis of the pulmonary artery bifurcation and 1 
patient had atrioventricular valve regurgitation. 
The surgical approach consisted of cardiopulmonary 
bypass (CPB) with direct caval cannulation, core cooling, 
and myocardial protection with cold blood cardioplegia. 
The following ~¢pes of operations were performed: 
!. Atriopulmonary connection was performed in 64 patients 
with atrial septal defect closure (in patients with tricuspid 
atresia) or with atrial neoseptation. A polytetrafluoroeth- 
ylene (PTFE) patch was used to close the defect. 
2. Total cavopulmonary connection was performed in 138 
patients. Three variations of the operation were used: 
Table I. Underlying diagnosis in the patients' 
undergoing Fontan procedure 
Diagnosis No. 
Tricuspid atresia 62 
DORV, VSD, PS with small LV or RV 55 
D-TGA, VSD, PS with small LV or RV 15 
L-TGA, VSD, PS with small LV or RV 20 
Single ventricle with or without PS 37 
Tetralogy of Fallot with small LV 4 
Tumor of RV 1 
Pulmonary atresia with intact ventricular septum 1 
Hypoplastic right eart syndrome 5 
Total anomalous pulmonary venous drainage 2 
with functional single ventricle 
Total 202 
DORV, Double-outlet right ventricle; VSD, ventricular septal defect; PS, 
pulmonary stenosis; LV,, left ventricle; RV,, right ventricle, D-TGA, Trans- 
position of great arteries; L-TGA, congenitally corrected transposition f 
great arteries. 
3. 
type A--total  cavopulmonary connection with a lateral 
atrial tunnel from the inferior vena cava to the superior 
vena cava using a PTFE patch (n = 108); type B--total 
cavopulmonary connection with a lateral tunnel cre- 
ated with interatrial septnm (n = 25); type C--bi lateral 
bidirectional superior cavopulmonary connection with 
diversion of the inferior vena cava to the left pulmo- 
nary artery via the coronary sinus (n = 5). 
A fenestrated Fontan operation was performed with a 
4 or 5 mm coronary punch in the last 20 patients: 
atriopulmonary connection, n = 8; total cavopulmo- 
nary connection type A, n = 11; and total cavopulmo- 
nary connection type B, n = 1. 
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Table II. Associated procedures 
No. 
Takedown of Blalock-Taussig shunt 
Takedown of Waterst0n shunt 
Pulmonary artery debanding 
Atrioventricular valve repair 
Pulmonary arter{oplasty 
Total anomalous pulmonary venous 
drainage repair 
Subaortic resection 
58 
1 
3 
1 
15 
2 
1 
Table IIL Causes of early death 
No. 
Hemodynamic Fontan failure 15 
Sepsis 6 
Pulmonary embolism 2 
Intractable supraventricular tachycardia 2 
Respiratory failure 2 
Unexplained sudden death 1 
Neurologic 2 
Total 30 
Associated procedures are listed inTable II. Four patients 
also had preexisting bidirectional superior cavopulmonary 
connection and underwent Fontan completion, 
Results 
All patients who died within 30 days of the 
operation and all who Survived Fontan takedown 
were included in the category Fontan failure. This 
designation may not be strictly true inasmuch as 
obvious hemodynarnic Fontan failure was present in 
only 19 patients. Hemodynamic Fontan failure was 
defined as low cardiac output after a Fontan-type 
repair, with persistent need to maintain central 
venous pressure higher than i8 mm Hg and/or 
inordinately high fluid requirement to maintain ac- 
ceptable systemic perfusion. The immediate causes 
of death are included in Table III. Some of the 
deaths (n = 15) not caused by hemodynamic Fontan 
failure (causes 2 to 7) may have been the result of 
chronic low cardiac output with elevated systemic 
venous pressure. Others were relatively sudden ter- 
minal events in seemingly satisfactory postoperative 
recoveries. To eliminate any bias in including pa- 
tients in or excluding them from the category of 
Fontan failure, we included all deaths within 30 days 
of operation in the broad category of Fontan failure. 
Any pleural effusion that lasted for more than 10 
days after the operation was called significant. Any 
pleural effusion that recurred after chest tube re- 
moval was also included in the list of significant 
effusions. 
Early results. Thirty-four patients were included 
in the category Fontan failure: four who survived 
Fontan takedown and 30 who died within 30 days. 
The four patients who survived Fontan failure had 
conversion to bidirectional superior cavopulmonary 
connection immediately (n = 3) or within 24 hours 
(n = 1). Six patients had conversion to bidirectional 
superior cavopulmonary connection more than 48 
hours after Fontan repair and one patient was 
treated by fenestration of the atrial baffle within 24 
hours. None of these patients survived. In one 
patient with a fenestrated Fontan the repair was 
converted to a bidirectional Glenn shunt immedi- 
ately, but the patient later died of low cardiac 
output. The other seven patients with hemodynamic 
Fontan failure died without any additional proce- 
dure (takedown/fenestration) being performed. 
Durations of CPB and aortic crossclamping as 
risk factors for Fontan failure and significant effu- 
sion were analyzed initially by considering both of 
the independent variables to be continuous variables 
using the Wilcoxon rank-Sum test for two groups. 
Then distribution of both CPB and aortic Cross- 
clamp time were analyzed to find a Clinically useful 
cutoff point at which the incidence of Fontan failure 
or effusion started to rise significantly. For the CPB 
time the cutoff point was found to be 120 minutes 
and for aortic crossclamp time it was 60 minutes. 
Multivariate analysis of all the risk factors howed 
results imilar to those derived by univariate analy- 
sis; that is, CPB time greater than 120 minutes is a 
significant risk factor for both Fontan failure and 
effusion, and aortic crossclamp time greater than 60 
minutes is a significant risk factor for significant 
effusion only. All other isk factors were found to be 
insignificant. 
Table IV shows the risk factors for Fontan failure 
and related p values. There is no statistically signif- 
icant difference in early mortality in patients of 
different age groups (p > 0.3). Age distribution and 
Fontan failure in different age groups are shown in 
Fig. 1. 
Fontan failure and early postoperative mortality 
were more prevalent in patients having a CPB time 
of more than 120 minutes than a shorter CPB time 
(p < 0.02), whereas long aortic rossclamp time 
(p > 0.7) did not affect the early postoperative 
outcome. The incidence of Fontan failure was sim- 
ilar in patients with atriopulmonary connection (12/ 
64) and in those with total cavopulmonary connec- 
tion (22/138) (p > 0.5). 
The Journal of Thoracic and 
Cardiovascular Surgery 
Volume 110, Number 6 
Sharma et al. 1 6 9 5 
Associated procedures like takedown of an arte- 
rial shunt (p > 0.4), pulmonary artery debanding 
(p > 0.4), or puhnonary arterioplasty (p > 0.3) did 
not affect early mortality (see Table IV). 
Four patients had a bidirectional Glenn shunt as 
interim palliation. This small group of patients was 
potentially predisposed to Fontan-related complica- 
tions because of greater number of risk factors 
(average number of Choussat criteria violated 2.25) 
than were those patients undergoing Fontaia repair 
without staging (average number of Choussat crite- 
ria violated 0.59). No mortality or significant effu- 
sion occurred in this group of patients with non- 
fenestrated Fontan repairs. This difference did not 
achieve statistical significance (p > 0.3). 
Fontan failure occurred in nine of 62 patients with 
tricuspid atresia and in 25 of 140 patients without 
tricuspid atresia. This difference is statistically insig- 
nificant (p > 0.6). 
This retrospective study may be divided into two 
study periods: 1990 to 1993, when all patients had 
nonfenestrated interatrial baffles, and 1994, when all 
patients underwent a fenestrated Fontan procedure. 
Analysis of patients in both study periods reveals no 
significant preoperative difference in patient charac- 
teristics (Table V). 
Fontan failure was encountered in 33 of 182 
patients having nonfenestrated Fontan repairs (29 
early deaths and four takedown survivors). One 
Fontan failure occurred in the 20 consecutive pa- 
tients having fenestrated Fontan repair. This patient 
had a concomitant repair of total anomalous pulmo- 
nary venous connection and died of respiratory 
infection and disseminated intravascular coagula- 
tion after takedown. The small number of patients 
in the fenestration group prevents the difference 
from becoming statistically significant (p > 0.1) (Fig. 
4, Table VI). 
Seventy patients (34.7%) had persistent pleural 
effusion for more than 10 days. Incidence of effusion 
was similar in different age groups, in patients with 
different ypes of Fontan operations, and in patients 
with or without the diagnosis of tricuspid atresia, 
with or without baffle fenestration (Table VII). 
However effUsion was significantly more prevalent 
when aortic crossclamp time exceeded 60 minutes 
(p < 0.03) or CPB time exceeded 120 minutes (p < 
0.05) (Tables VIII and IX). 
Midterm results of nonfenestrated Fontan repair. 
The follow-up period for nonfenestrated Fontan 
repair ranged from 12 months to 54 months. There 
were six late deaths among these patients; two 
Table IV. Risk factors for early mortality and 
Fontan fi~ilure 
p Value 
Early Fontan 
Risk factor mortality failure 
Age 0.3974 0.1010 
Type of operation 0.5249 0.6197 
Absence of fenestration 0.1918 0.1362 
Takedown of Blalock-Taussig shunt 0A432 0.7003 
CPB time >120 min* 0.0187 0.0129 
Aortic crossclamp time >60 rain 0.7215 0.8580 
Pulmonary artery size 0.4393 0.6481 
Other than tricuspid atresia 0.6043 0.5583 
Pulmonary arterioplasty 0.3542 0.7066 
Previous pulmonary artery band 0.4661 0.4324 
One-stage Fontan procedure 0.3989 0.3635 
*Significant risk factor for early mortality and Fontan failure. 
patients died of pneumonia, one of protein-losing 
enteropathy, and one during reoperation for baffle 
leak and residual pulmonary artery stricture. One 
patient died of refractory ventricular fibrillation 
during surgical pleurodesis for recurrent pleurai 
effusion. One patient had acute pancreatitis and 
died after exploratory laparotomy. 
Five patients of the nonfenestrated group were 
lost to follow-up. A total of 142 patients with a 
nonfenestrated atrial baffle have been followed up 
in the past 6 months; 124 were receiving no 
cardiac medicines and were in New York Heart 
Association functional class I. The remaining 18 
patients were receiving diuretics with or without 
vasodilators and were in New York Heart Asso- 
ciation functional class II (15 patients) or III (3 
patients) (Fig. 5). 
Midterm results of fenestrated Fontan repair. 
One late death (cause unknown) occurred in the 
group of patients receiving fenestrated intraatrial 
baffles. All 18 surviving patients with fenestrations 
have been followed up for 2 to 11 months, All of 
them are tree of symptoms (class I) and require no 
cardiac medications (Fig. 5). 
Oxygen saturation ranged from 85% to 94% in 
patients having a 4 mm fenestration (n = 14) and 
from 80% to 85% in patients having a 5 mm 
fenestration (  = 4) at a mean follow-up period of 5 
months. Four of these patients had spontaneous 
closure of their fenestration as demonstrated bylack 
of any right-to-left shunt by contrast echocardiogra- 
phy. None of the patients with fenestrations have 
been taken up for closure of the fenestration. 
1696 Sharma et al. 
The Journal of Thoracic and 
Cardiovascular Surgery 
December 1995 
140 
120 
100 
80 
60 
40 
20-  
0 
Number 
,60 MINUTES ,60 MINUTES 
Duration of Aortic Cross Clamp 
1 Total No. ~ No.of Effusion [ [ Fontan Failure 
p value for effusion • 0.0278 
p value for Fontan failure • 0.8580 
Fig. 2. Duration of aortic crossclamp and incidence of effusion and Fontan failure. 
180 
160 
140 
120 
100 
80 
60 
40 
20 
0 
Number 
(120 MINUTES ,120 MINUTES 
Duration of Cardiopulmonary bypass 
i 1  Total No. ~ No.of Effusion [---7 Fontan Failure 
p value for effusion • 0.0456 
p value for Fontan failure - 0.O129 
Fig. 3. Duration of CPB and incidence of effusion and Fontan failure. 
Discussion 
Because of the difficulty in separating the non- 
Fontan failure deaths from the Fontan failure 
deaths without bias, all deaths within 30 days of 
repair were included in the heading Fontan failure. 
Some of the deaths would not fall strictly under the 
hemodynamic definition of Fontan failure but for 
the reason mentioned earlier are included in this 
category. 
We have followed a strict policy of selecting 
patients for the Fontan procedure 17-19 with refer- 
ence to pulmonary artery size, pulmonary artery 
distortion, and ventricular function. However, inas- 
much as the majority of patients had severe pulmo- 
nary stenosis, were severely cyanotic, and underwent 
the Fontan procedure as their first intervention, 
pulmonary artery entry was the exception at preop- 
erative cardiac catheterization. A preoperative pul- 
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monary artery pressure reading was therefore not 
available, although it could be estimated echocar- 
diographically or directly recorded uring the oper- 
ation. Hence calculations of pulmonary vascular 
resistance were not commonly available. 
Possibly because of the unavailability of preoper- 
ative data, a Fontan failure rate of 18.1% (33/182) 
was encountered in the first part of the experience 
when only nonfenestrated univentricular epairs 
were performed. Fenestration of the interatrial baf- 
fle probably acts as a safety valve for such patients o 
that cardiac output is preserved at the cost of 
systemic arterial desaturation even in patients with 
an elevated pulmonary vascular esistance index. 
Unlike the usual patient population referred for 
Fontan repair in the Western hemisphere, most of 
our patient population had not undergone palliation 
and was severely cyanosed. For those two reasons, 
only infrequently were pulmonary artery pressure 
and pulmonary vascular esistance index determined 
in the preoperative period. This article highlights 
the role of routine fenestration i providing a vent 
to combat undiagnosed elevations of pulmonary 
vascular esistance index that were probably result- 
ing in high Fontan failure rates in nonfenestrated 
repair. 
Oxygen saturation ranged between 85% and 94% 
in patients with 4 mm fenestration and 80% and 
85% in those with 5 mm fenestrations. Four patients 
had no evidence of right-to-left shunting through 
the baffle. We have not made any attempts at closing 
fenestrations because of the excellent symptomatic 
status of patients and reluctance of the children's 
parents to subject hem to further intervention. 
Our overall early mortality rate of 14.9% com- 
pares favorably with those of other series. 13' 2o More 
liberal use of the fenestrated Fontan approach as 
reduced the mortality to 5%. The only patient who 
died (among 20 having the fenestrated Fontan pro- 
cedure) had conversion to a bidirectional Glenn 
shunt on the operating table because of difficulty in 
weaning from CPB after fenestrated atriopulmonary 
connection and total anomalous pulmonary venous 
drainage repair. Improvement in early results with 
the fenestrated Fontan approach ad been reported 
previously.~9' 2~ 
Fontan and associates 22(1983) reported that age 
at operation (<4 years or >15 years) was a signifi- 
cant risk factor (p < 0.001) for early mortality. Table 
IV shows the wtrious risk factors for early mortality 
in our series. There was no statistically significant 
difference in mortality among patients of different 
Table V. Comparison of preoperative status of 
patients undergoing fenestrated and nonfenestrated 
Fontan operation 
Fenestrated Nonfenestrated 
(n = 2O) (n = 182) 
Mean age (yr) 7.68 7.29 
Standard eviation 3.95 6.33 
Mean McGoon Ratio 2.50 2.46 
Standard eviation 0.48 0.57 
Mean PA pressure (mm Hg) 11.50 10.96 
Standard eviation 6.97 5.03 
LVEDP (mm Hg) 11.00 10.68 
Standard eviation 0.82 4.24 
Percent with PA bifurcation 25 5.5 
stenosis 
Percent with Choussat criteria 
violations 
None 50 47.8 
One 40 44.0 
Two 10 8.2 
PA, Pulmonary artery; LVEDP, left ventricular end-diastolic pressure. 
age groups (p > 0.3). Other workers have also noted 
that age does not exert significant influence on 
survival.17' 23 Possibly use of a strict selection criteria 
has eliminated this risk factor. 
One category of patients, albeit small, was devoid 
of any significant effusion or Fontan failure. Patients 
who had had an interim palliation by means of a 
bidirectional Glenn shunt had neither Fontan fail- 
ure nor effusions on Fontan completion. This possi- 
ble advantage has been mentioned before. 12 This 
finding attains greater significance because these 
patients had a higher number of Fontan risk factors 
(average number of Choussat criteria violated 2.25) 
than those coming directly to Fontan repair (aver- 
age number of Choussat criteria violated 0.59). 
The superiority of one modification of the Fontan 
operation over the other cannot be substantiated in 
our series, because there is no significant difference 
in early mortality among the patients receiving 
different ypes of total cavopulmonary or atriopul- 
monary connection (p > 0.5). The choice of one 
procedure over the other was dictated by the surgi- 
cal anatomy in a particular case, and this fact 
highlights the importance of performing a nonre- 
strictive anastomosis between the systemic veins and 
the pulmonary artery rather than preferring a par- 
ticular modification of the Fontan procedure. 
In our series, early mortality was positively corre- 
lated with CPB time longer than 120 minutes (p < 
0.02). Longer bypass time was often associated with 
complex repair procedures. 
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Table VI. Incidence of early mortality, Fontan 
failure, and effusion in patients with fenestrated and 
nonfenestrated baffle 
Total Early Fontan Significant 
[ntraatrial baffle No. mortality failure effusion 
Fenestrated 20 1 1 6 
Nonfenestrated 182 29 33 64 
p Value 0.1918 0.1362 0.6450 
The damaging effects of CPB are amplified as 
total CPB time increasesY Although we do not 
have evidence of whole body inflammation (e.g., 
complement levels), analysis of CPB time as a 
continuous variable highlights the progressively in- 
creasing risk with longer duration of CPB, with 
values reaching statistical significance at a CPB time 
exceeding 120 minutes. 
Interference with integrity of the capillary endo- 
thelium resulting in "capillary leak syndrome ''24 
may contribute to the prevalence of effusion after 
longer periods of CPB. This would be further com- 
pounded by elevated systemic venous pressure that 
results after univentricular epair. Postoperative 
persistent effusions into body cavities had been 
traditionally explained by increased venous pres- 
sure. Our findings uggest that increased duration of 
CPB may be an etiologic factor too, along with 
increased venous pressure. 
Longer aortic crossclamp time (despite cardiople- 
gic protection), with attendant greater myocardial 
cell damage and myocardial dysfunction, would also 
Table VII. Risk factors for effusion 
Risk factor p Value 
Age 0.8577 
Type of operation 0.3125 
Absence of Fenestration 0.6450 
Takedown of BT shunt 0.8848 
CPB time >120 min* 0.0456 
Aortic crosselamp time >60 min* 0.0278 
Pulmonary artery size 0.8644 
Patients other than tricuspid atresia 0.8689 
Pulmonary arterioplasty 0.9111 
*Significant risk factor for effusion. 
result in a higher central venous pressure, thereby 
compounding the damaging effects of CPB. 
It can therefore be inferred that a complete 
Fontan procedure is best avoided when complex 
repair is to be undertaken. However, associated 
procedures like takedown of classic or modified 
Blalock-Taussig shunts (p > 0.4), pulmonary arte- 
rioplasty (p > 0.3), or pulmonary artery debanding 
(p > 0.9) did not increase arly mortality (see Table 
IV). Mayer and associates is had noted that pulmo- 
nary artery distortion from a previous palliative 
procedure increased the risk of early death. How- 
ever, in our series previous palliative procedures 
were not associated with increased risk of either 
early death or postoperative effusion. In fact, the 
early mortality among 15 patients who underwent 
pulmonary arterioplasty was 6.7% (1\15) compared 
with an overall mortality of 14.9% (p > 0.3). This 
difference can be explained by wider use of the 
bidirectional Glenn shunt in patients in whom a less 
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Table VIII. Incidence of early mortality, Fontan 
failure, and e)fusion in patients with different 
durations of CPB 
Total Early Fontan Significant 
CPB time No. mortality failure effusion 
<120 min 155 18 20 48 
>120 min 47 12 14 22 
p Value 0.0187 0.0129 0.0456 
Table IX. Incidence of early mortality, Fontan 
failure, and effusion in patients with different 
durations of crossclamping 
Crossclamp Total Early Fontan Significant 
time No. mortality failure effusion 
<60 rain 122 19 21 35 
>60 min 80 11 13 35 
p Value 0.7215 0.8580 0.0278 
than satisfactory pulmonary arterioplasty was 
achieved. 
Debate continues regarding the suitability of the 
one-stage complete Fontan procedure in patients 
with borderline pulmonary artery size. The success- 
ful outcome of the Fontan procedure is mainly 
dependent on low pulmonary vascular esistance. 
Senzaki and coworkers 25 concluded that smaller 
pulmonary artery size was hemodynamically disad- 
vantageous after the Fontan procedure because it 
increased peak central venous pressure. They have 
not shown the effects of smaller pulmonary artery on 
ultimate outcome. We calculated the McGoon ratio 
in our cases and found no significant difference in 
incidence of either early mortality (p > 0.4) or 
effusion (p > 0.8) in patients with different pulmo- 
nary artery sizes. 
The prevalence of effusion (persisting more than 
10 days) in our series is positively correlated with the 
duration of aortic crossclamping exceeding 60 min- 
utes (p < 0.03) and the duration of CPB exceeding 
120 minutes (p < 0.05). 
Experience has shown that Fontan failure should 
be treated aggressively. When takedown to bidirec- 
tional superior cavopulmonary connection was per- 
formed within 24 hours of the Fontan operation, the 
outcome was successful, whereas a delay of more 
than 48 hours resulted in multiorgan failure, leading 
to death. 
Conclusion 
Early mortality is higher if CPB time exceeds 120 
minutes, suggesting that complicated reconstructive 
procedure should be avoided with a complete Fon- 
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tan procedure. The incidence of effusion is related 
to the duration of aortic crossclamping and to the 
duration of CPB (see Figs. 2 and 3). In the past year, 
by adopting the fenestrated Fontan approach for all 
cases, we have been able to reduce mortality after 
the Fontan operation. Whether small (4 ram) fen- 
estrations should be closed at all is a question that 
still needs to be addressed. 
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Discussion 
Dr. John E. Mayer (Boston, Mass.). We agree with a 
number of the conclusions you have reached, for example, 
that a fenestrated Fontan seems to be the preferable 
technique and that if a patient with a Fontan repair is
failing, then the decision to take it down to a bidirectional 
cavopulmonary shunt should be made early. 
I would like to clarify one aspect regarding some of our 
prior publications, and, in particular, the issue of pulmo- 
nary artery distortion as a risk factor, In our previously 
reported series, pulmonary artery distortion that could not 
be repaired, in other words, unrepaired pulmonary artery 
distortion, was almost universally associated with failure, 
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whereas a repairable pulmonary artery distortion was a 
less powerful risk factor. 
I have some questions about some of the other conclu- 
sions that you have reached. You had little preoperative 
data on pulmonary vascular resistance and only inferential 
data from echocardiograms on pulmonary artery pressure. 
Inasmuch as the pulmonary artery pressure measured in 
an open chest, anesthetized patient may not be closely 
related to that measured in a catheterization laboratory, it 
would be difficult to conclude that pulmonary artery 
pressure is not a risk factor for Fontan operations. Alter- 
natively, if pulmonary artery pressure was low in all 
patients, then it would be unlikely to appear as a risk 
factor either. Can you tell us the number patients in whom 
pulmonary artery pressure was directly measured and how 
many really had a significant elevation in the pulmonary 
artery pressures? 
Second, you have concluded that age was not a risk 
factor, but you have not told us how this variable was 
evaluated. Was it analyzed as a continuous variable or was 
it considered only as age outside the classic 4- to 15-year 
age range? 
Finally, you have mentioned that approximately 50% of 
the patients exceeded one or more of the Choussat- 
Fontan limits. Can you tell us which limits were exceeded 
and with what frequency? There is some danger in simply 
counting the number of deviations from those classic 
criteria, because that assumes that all of the criteria have 
an equally important impact on outcome. Our prior 
studies and those of others would suggest that some of the 
criteria either are not important or are of much greater 
impact han others of the original Fontan criteria. 
Dr. Sharma. Thank you, Dr. Mayer. You are correct in 
observing that we had little information on pulmonary 
vascular esistance and that a majority of our pulmonary 
artery pressure measurements were done in the operating 
room. In the risk factors that we analyzed, we did not 
include pulmonary artery pressure because we performed 
a Fontan repair only if the pulmonary artery pressure was 
less than a mean of 18 mm Hg. I also agree with your 
observation that the pulmonary artery pressure measure- 
ments in the operating room may not accurately represent 
the true state of the existing circulation. This is probably 
the reason that the Fontan failure rate was high before we 
started using fenestrations; that is, a failure rate of about 
18% when we were really adhering closely to the other 
prescribed guidelines for Fortran selection. Also, since we 
started using fenestrated banes in the last 20 patients 
(and there have been another 10 to date), mortality has 
decreased substantially. Our impression is that borderline 
pulmonary vascular resistance and pulmonary artery pres- 
sure elevations (undetected in the open chest, anesthe- 
tized patient) probably contributed to the excessive mor- 
tality in the group with nonfenestrated banes. Whatever 
marginal elevation of pulmonary vascular esistance or 
pulmonary artery pressure was present caused the fenes- 
trations to decompress from right to left without compro- 
mising cardiac output (albeit with some amount of desatu- 
ration, which improved on follow-up). 
We have analyzed age both as to whether it fell outside 
the classic Fontan criteria of 4 to 15 years and as a 
continuous variable, and we did not find it to be a 
significant risk factor. Of course, only five of our patients 
were younger than 1 year of age, and only 22 were younger 
than 2 years. 
Fontan criteria violations included age, pulmonary ar- 
tery size, pulmonary artery distortion, and atrioventricular 
valve regurgitation. Pulmonary artery pressures were all 
less than 18 mm Hg (mean). Not having any information 
on pulmonary vascular esistance index, we did not in- 
clude it in our analysis. No Fontan criteria were violated in 
50% of the cases, one criterion in 40%, and two or more 
criteria were violated in 10% of the patients. No statisti- 
cally significant difference in Fontan failure or effusion 
rate was detected between any of these patients groups. 
Dr. Frank L. Hanley (San Francisco, Calif.). Before 1 
make my comment, I would like to emphasize that it is not 
meant o be critical of the fenestrated Fontan itself. In a 
very large series of patients with univentricular heart 
disease such as this, in which institutional learning curves 
are extremely important and many parameters are rapidly 
changing, it is important to be careful about the way the 
conclusions are drawn. In a series of over 200 cases, to 
examine just the last 20 cases (which were fenestrated) 
and compare them to the previous 180 or so cases and 
conclude that all of the differences between the two 
groups were due to the fenestration may not be valid. A 
more sophisticated analysis that takes into account a 
number of other potentially important variables would be 
necessary before one can conclude that the benefits are all 
due to introduction of the fenestration. 
Dr. Sharma. Thank you, Dr. Hanley. The distribution 
of cases between the two groups is definitely unequal and 
the time periods are different. However, since we began 
doing univentricular repairs in our center, we had a 
consistent Fontan failure rate of more than 15% until we 
switched over to fenestrating all our intraatrial baffles. 
The mortality figures then dropped markedly and 
abruptly. Nevertheless, your objection to our conclusion is
still valid. The only way we could prove whether a 
fenestration really helps would be to perform a random- 
ized trial between two comparable patient groups. 
